Clinical Trial Update: Study To Evaluate The Impact Of Anti-Cyclic Citrullinated Peptide(Anti-CCP) For Management With Enbrel In Patients With Psoriatic Arthritis(PsA)

View source ↗

Summary

A completed clinical trial evaluating the impact of anti-CCP therapy for management with Enbrel in patients with psoriatic arthritis; results were posted in 202…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• ENBREL (etanercept)

Snippet

Sponsor: Pfizer | Conditions: Psoriatic Arthritis | Status: COMPLETED | Results posted: 2021-09-14